A. Nathwani

Current status and prospects for gene therapy

R. Benjamin, A. Nienhuis, A. Davidoff, 2004, Vox sanguinis.

Successful attenuation of humoral immunity to viral capsid and transgenic protein following AAV-mediated gene transfer with a non-depleting CD4 antibody and cyclosporine

A. Davidoff, H. Waldmann, S. Cobbold, 2011, Gene Therapy.

SYSTEMIC VASCULITIS AND MYELODYSPLASIA

I. Reilly, A. Nathwani, A. Warren, 1990, British journal of haematology.

NF-κB activation mediates resistance to IFNβ in MLL-rearranged acute lymphoblastic leukemia

L. Pfeffer, A. Davidoff, L. Tracey, 2010, Leukemia.

Enhancing transduction of the liver by adeno-associated viral vectors

J. Gray, A. Davidoff, J. Mcintosh, 2009, Gene Therapy.

Prospects for gene therapy of haemophilia

A. Davidoff, E. Tuddenham, A. Nathwani, 2004, Haemophilia : the official journal of the World Federation of Hemophilia.

Maturation of tumor vasculature by interferon-beta disrupts the vascular niche of glioma stem cells.

A. Davidoff, H. Poppleton, A. Myers, 2010, Anticancer research.

Adenovirus-mediated expresssion of the murine ecotropic receptor facilitates transduction of human hematopoietic cells with an ecotropic retroviral vector

A. Nienhuis, D. Persons, A. Mcclelland, 1999, Gene Therapy.

Antitumor efficacy of AAV-mediated systemic delivery of interferon-β

J. Gray, A. Davidoff, C. Ng, 2006, Cancer Gene Therapy.

Management of chronic myeloid leukaemia in lymphoid blast transformation.

J. Goldman, A. Nathwani, 1993, Haematologica.